The drugmaker#39;s net profit for the quarter plummeted to Rs 78.6 crore due to high base on account of COVID sales and a shutdown of production line in the Pashamylaram Penems facility for line upgradation.
The drugmaker#39;s net profit for the quarter plummeted to Rs 78.6 crore due to high base on account of COVID sales and a shutdown of production line in the Pashamylaram Penems facility for line upgradation. The drugmaker#39;s net profit for the quarter plummeted to Rs 78.6 crore due to high base on account of COVID sales and a shutdown of production line in the Pashamylaram Penems facility for line upgradation. Moneycontrol Latest News Read More
हिन्दी 
English